USPTO 2015–2025 USPTO PatentsView US Corporation

Enzo Life Sciences, Inc.

USPTO PatentsView assignee record - 55 granted patents across 16 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Enzo ranks #6,140 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 16 technology areas.

#6,140
of 49,997 US assignees by volume
Top 30%
by Innovation Score (42.8/100)
21.8
avg claims per patent
-62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6140 · US Corporation #6,140 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 55 grants
  • UPPER-Q #6,140/49,997
  • PHOTO-FINISH Dental Imaging
  • CPC-FOCUS C12Q · 16 areas
  • INNOV-PAR 42.8/100
  • CLAIMS-DENSE 21.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -62% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dental Imaging Technologies Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Enzo

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Enzo's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Enzo's grants concentrate

Enzo Life Sciences, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 85.5% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2016 (15 grants) versus a trough of 1 in 2023. By volume, Enzo sits between Dental Imaging Technologies Corporation and Entellus Medical, Inc..

Enzo's three-year grant acceleration

Enzo Life Sciences, Inc. shows 4 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Enzo's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Enzo holds 55 patents at rank #6,137, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Enzo

By rank, the assignees closest to #6,137 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Enzo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Enzo, neither rank-band nor same-CPC leaders (those blocks stay above).

Enzo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201520162017201820192020202120232024 3
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Enzo Life Sciences, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 7 12.7%
2016 15 27.3%
2017 8 14.5%
2018 5 9.1%
2019 5 9.1%
2020 6 10.9%
2021 5 9.1%
2023 1 1.8%
2024 3 5.5%

Where it ranks

Overall rank by patents

#6,140

of 49,997 tracked assignees

Innovation Score

42.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Enzo Life Sciences, Inc.'s patent record in context - here's where to go next.

  • Enzo Life Sciences, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 85.5% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #6,140 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Enzo Life Sciences, Inc. against Dental Imaging Technologies Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.